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Abstract  
Mitochondria are important (patho)physiological sources of reactive oxygen species (ROS) that mediate 
mitochondrial dysfunction and phospholipid oxidation; an increase in mitochondrial content of oxidised 
phospholipid (OxPL) associates with cell death.  
Previously we showed that the circulating OxPL 1-palmitoyl-2-(5'-oxo-valeroyl)-sn-glycero-3-
phosphocholine (POVPC) increases in patients with Alzheimer’s disease (AD), and associates with 
lower plasma antioxidant oxocarotenoids, zeaxanthin and lutein. Since oxocarotenoids are metabolised 
in mitochondria, we propose that during AD, lower concentrations of mitochondrial zeaxanthin and 
lutein may result in greater phospholipid oxidation and predispose to neurodegeneration.  
Here, we have investigated whether non-toxic POVPC concentrations impair mitochondrial metabolism 
in differentiated (d)SH-SY5Y neuronal cells and whether there is any protective role for oxocarotenoids 
against mitochondrial dysfunction. After 24 hours, glutathione (GSH) concentration was lower in 
neuronal cells exposed to POVPC (1-20µM) compared with vehicle control without loss of viability 
compared to control. However, mitochondrial ROS production (determined by MitoSOX oxidation) 
was increased by 50% only after 20µM POVPC. Following delivery of lutein (0.1-1µM) and zeaxanthin 
(0.5-5µM) over 24 hours in vitro, oxocarotenoid recovery from dSH-SY5Y cells was >50%. Co-
incubation with oxocarotenoids prevented loss of GSH after 1µM but not 20µM POVPC, whereas the 
increase in ROS production induced by 20µM POVPC was prevented by lutein and zeaxanthin. 
Mitochondrial uncoupling increases and ATP production is inhibited by 20µM but not 1 µM POVPC; 
carotenoids protected against uncoupling although did not restore ATP production. 
In summary, 20µM POVPC induced loss of GSH and a mitochondrial bioenergetic deficit in neuronal 
cells that was not mitigated by oxocarotenoids.  
Keywords  
Carotenoids, oxidative stress, mitochondria, viability, oxidised phospholipids, lutein, zeaxanthin, 
bioenergetics, POVPC
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INTRODUCTION  
Reactive oxygen species (ROS) are produced during mitochondrial oxidative phosphorylation. 
Increased mitochondrial-derived ROS are associated with mitochondrial dysfunction and have been 
described as early events in neurodegenerative diseases [1–4]. In a vicious cycle of oxidative damage 
and ROS production, the oxidation of mitochondrial proteins, DNA and lipids precedes a decline in 
mitochondrial integrity. Several phospholipid oxidation products are cytotoxic at the site of production 
and have the potential to cross biological membranes of neighboring cells to exert distant effects [5–7]. 
This has been shown in cardiomyocytes, which are sensitive to exposure to cytotoxic oxPL and also 
accumulate mitochondrial OxPL during ischemia reperfusion and preceding cell death [8]. 
Carotenoids can quench singlet oxygen and scavenge other ROS without being consumed in the process 
except when scavenging peroxides [9–11].  While a Cochrane systematic review concluded that beta-
carotene supplements confer an increased risk of mortality  [12], the oxygen-containing carotenoid 
hydrocarbons, xanthophylls, which include lutein, zeaxanthin and meso-zeaxanthin have shown more 
promise for positive health outcomes [11]. Lutein and zeaxanthin cannot be synthesized by humans and 
are obtained from the diet or supplements. The consumption of diet rich in fruits and vegetables as well 
as the modification of nutritional habits and lifestyle associates with higher oxocarotenoid levels in 
plasma and a lower risk of age-related diseases and AD [13].  Conversely, in the MARKAGE study, 
lower levels of β-cryptoxanthin and zeaxanthin were observed in the cognitively frail [14].  
The discrete risk/benefit effects of carotenoids that have been observed in vivo may relate to their 
distinctive metabolism; oxocarotenoids are differentially distributed within subcellular compartments 
and are associated with specific metabolic enzymes [15]. In contrast to carotene which is metabolised 
by BCO1 and is retained in the cytoplasm, the enzyme BCO2 is associated with the inner mitochondrial 
membrane and metabolizes zeaxanthin (which accumulates in the inner mitochondrial membrane) into 
long-chain apo-carotenoids. BCO2 functions as a key regulatory enzyme that prevents toxicity caused 
by carotenoid accumulation and loss of BCO2 function is associated with the development of 
mitochondrial oxidative stress and metabolic diseases [16].  
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Others have shown that chronic administration of the oxocarotenoid lycopene significantly restores the 
mitochondrial respiratory enzyme activities in Aβ42 treated rats and attenuated mitochondrial oxidative 
stress. These observations suggest a role for carotenoids in maintaining mitochondrial integrity in brain 
[17]. Our own work has shown that lutein, lycopene, and zeaxanthin concentrations were significantly 
lower in AD patients with vascular co-morbidities compared to healthy subjects [18].  In another study 
we have shown that the serum phospholipid oxidation product POVPC was higher in AD compared 
with age-matched control subjects but was not reduced by carotenoid supplementation in extant disease 
[19]. Taken together these studies indicate an inverse relationship between carotenoid concentration 
and the oxidised phospholipid POVPC in AD.  
We hypothesise that during AD development, lower concentrations of systemic carotenoids are 
reflected by lower brain mitochondrial zeaxanthin and lutein, greater phospholipid oxidation and 
contribute to neurodegeneration via oxidative and metabolic stress.  To investigate this hypothesis, here 
we have investigated any protective role for carotenoids against mitochondrial dysfunction induced by 
POVPC (1-20µM) in differentiated (d)SH-SY5Y neuronal cells.  
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MATERIALS AND METHODS 
Human neuroblastoma SH-SY5Y cells were purchased from American Type Culture Collections, 
Manassas, USA. Authentic standards of lutein and beta-apo-8'-carotenal were purchased from Sigma 
Aldrich (Dorset, UK); zeaxanthin was purchased from Cambridge Biosciences (Cambridge, UK); 
carotenoid standards were kept in the dark, made up fresh and used immediately after preparation and 
confirmation of concentrations. 1-palmitoyl-2-(5’-oxo-valeroyl)-sn- glycero-3-phosphocholine 
(POVPC) was purchased from Avanti Polar Lipids (Alabaster, AL, USA); MitoSOXTM Red was 
purchased from Invitrogen (Fisher Scientific, Loughborough, UK); cell titre blue was purchased from 
Promega Corporation (Hollow Road, USA). All materials for the Extracellular Flux assays were from 
Agilent Technologies / Seahorse Biosciences / (Santa Clara, USA). Carbonyl cyanide p-
[trifluoromethoxy]-phenyl-hydrazone (FCCP), oligomycin, and antimycin A were from Sigma-Aldrich. 
All solvents used were HPLC grade from Fisher Scientific (Loughborough, UK). All other cell culture 
media and chemicals were also purchased from Fisher Scientific (Loughborough, UK) unless otherwise 
stated. 
 
Cell culture 
Routine cell culture 
SH-SY5Y cells were maintained routinely in RPMI 1640 media up to passage 20 and supplemented 
with heat inactivated 10% foetal bovine serum (FBS), 4 mM L-glutamine and 200 U/ml penicillin and 
200 µg/ml streptomycin at 37 °C in a humidified atmosphere of 5% CO2 and 95% air. Cells were seeded 
in a T75 flask at a density of 2x105cells/ml. 
 
Differentiation of neuroblastoma cells  
Cells were differentiated into neuronal-like cells for 10 days and medium was replaced at least every 
48 hours as described previously  [1,20]. Briefly, SH-SY5Y cells were exposed to 10 μM all-trans 
retinoic acid (RA) on day 1 after seeding. Medium was replaced with fresh RPMI routine culture 
medium containing RA every 48 hours. After 5 days the medium was changed to neurobasal media 
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containing (2M KCl, 100µg/mL BDNF; 2% B-27® Supplement (20 mL/L) and 400 U/ml penicillin / 
400 µg/ml streptomycin) for an additional 5 days; medium was replaced every 48 hours.  
SHSY5Y cell differentiation was measured by the extension of long neurites and the cessation of 
proliferation. The length of neurites was measured by image J software and a differentiated cell was 
defined as a cell with a neurite length greater than the length of the cell body (on average greater than 
10 μm in length). More than 80% SH-SY5Y cells displayed extended neurites after 10 day 
differentiation (Supplementary figure 1). 
Cell treatment with oxidised phospholipid and carotenoids 
After 10 days differentiation, SH-SY5Y cells were treated with POVPC (0, 1 and 20 µM) ± carotenoids 
(0.1, 1 and 10 µM lutein and 0.05, 0.5 and 5 µM zeaxanthin) as indicated for 24 hours at 37°C. Cells 
were washed with phosphate buffered saline (PBS) prior to analysis. 
 
Delivery of carotenoids to cells 
Plasma concentrations of lutein and zeaxanthin have been reported to be 0.3 and 0.1µM respectively 
[21]. Following up from our previous observations, we treated cells with lutein (0.1 and 1µM) and 
zeaxanthin (0.05, 0.5 and 5µM) in agreement with Wagener et al. [22]. Carotenoid stock solutions were 
prepared in tetrahydrofuran (THF) [23] and further diluted (1:1000) with neurobasal media. The vehicle 
treatment had no effect on any analyses. The concentrations of lutein and zeaxanthin were estimated 
using Beer Lambert’s law (Extinction coefficients in THF: Lutein-145100 l/(mol x cm); Zeaxanthin- 
144500 l/(mol x cm).  
 
Extraction of carotenoids from cells  
To ascertain the uptake of carotenoids by dSHSY-5Y cells after 24h exposure, we extracted carotenoids 
from washed, treated cells, using the protocol adapted from Wagener et al. [22]. SH-SY5Y cells were 
seeded in 100mm dishes at 2 x 106 cells/well, differentiated and then incubated in media containing 
different concentrations of lutein (0-10µM) and zeaxanthin (0-5µM) for 24 hours. The medium was 
then removed and cells were recovered by scraping in 1ml PBS. An aliquot of the sample was removed 
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for protein assay (BCA). For HPLC, 500µL THF and 0.5µM internal standard (trans-β-apo-8'-carotenal) 
was added to the cells and ultrasonicated for 10 minutes. 3mL hexane was used for the extraction of 
carotenoids and ultrasonicated for another 10 minutes. After centrifugation at 2000g, 20°C for 
10minutes, the organic phase was collected and the solvent was evaporated under nitrogen. The tube 
wall was rinsed with ether and allowed to dry for another 10 minutes. Pellets were re-suspended in 50µl 
THF and diluted with 100 µl HPLC buffer (54% methanol, 44% acetonitrile, 2% propan-2-ol, 15% 
water). Extraction was carried out in the dark. 
 
Assessment of metabolic activity 
Viability of cells and cytotoxicity of POVPC ± carotenoids were estimated using a cell titre blue assay. 
SH-SY5Y cells were seeded in a 24-well plate at 2x105 cells/well. After 10 days differentiation, cells 
were treated with POVPC ± carotenoids for 24 hours.  The cells were washed with PBS and incubated 
with media containing cell titre blue (1:5 dilution) in a 37°C incubator for 1-8 hours, protected from 
light. The supernatant was removed into a 96-well plate and the fluorescence was measured at 
excitation/ emission wavelengths of 560/590nm in a SpectroMax GeminiXS microplate fluorometer 
(Molecular Devices, USA); with the diluted dye as the blank. The absolute fluorescent values were 
calculated and plotted against the concentrations of the treatments. Loss of metabolic activity was 
evaluated by comparing results to the control sample which was taken to be 100% metabolically active.  
 
RNA isolation and SOD2 mRNA analysis 
Total RNA was isolated using the Qiagen RNeasy Mini Kit according to the manufacturer’s protocol. 
Briefly, SH5YSH cells were pelleted then suspended in RLT lysis buffer (provided) and homogenized 
by pipetting. To shear genomic DNA, the lysate was transferred to a gDNA spin column and 
centrifuged at 8000 x g that was primed with 70% (v/v) ethanol. The RNA was eluted adding 30 µL 
of RNase-free water and purity was assessed by NanoDrop ™ 1000/c (Spectrophotometers, Thermo 
Fisher Scientific,US). Quantitative PCR was then performed to determine SOD2 expression as 
previously described and using the following primers (f=forward; r=reverse).  
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Human SOD2-f    GTTCAATGGTGGTGGTCATATCA 
Human SOD2-r    GCAACTCCCCTTTGGGTTCT 
 
DNA isolation 
Total DNA from SH5YSH cells was obtained using Qiagen DNeasy kit according to manufacturer’s 
instructions. Briefly, the cell pellet was resuspended in 200 µl of PBS, followed by proteinase K 
(provided). For efficient lysis, buffer AL was added to the cells at 56 ° C for 10 minutes. To 
precipitate DNA, 96-100% ethanol was added, mixed by vortexing then transferred into a QIAamp 
mini column. After washing, samples were eluted from the column by centrifugation of the samples. 
DNA purity was detected by NanoDrop ™ 1000/c (Spectrophotometers, Thermo Fisher 
Scientific,US). DNA copy number was analysed as described previously here using the primers for 
tRNA-Leu(UUR) relative to B2-microglobulin as housekeeper.    
(https://currentprotocols.onlinelibrary.wiley.com/doi/abs/10.1002/0471142905.hg1907s68)  
Gene  Primers 
tRNA-Leu(UUR) Forward CACCCAAGAACAGGGTTTGT 
 Reverse TGGCCATGGGTATGTTGTTA 
B2-microglobulin Forward TGCTGTCTCCATGTTTGATGTATCT 
 Reverse TCTCTGCTCCCCACCTCTAAGT 
 
 
 
Mitochondrial isolation from cells  
Mitochondria were isolated from dSH-SY5Y by cell disruption followed by differential centrifugation 
using a method adapted from Lampl et al. [46]. First, mitochondrial isolation buffer (MIB) (70mM 
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sucrose, 210mM mannitol, 5mM HEPES, 1mM EGTA, pH 7.4) was prepared and stored at 4°C. All 
procedures were performed at 4°C. For the isolation of mitochondria, two T75 flasks of cells per 
treatment were used. Cells were washed in cold PBS. Following, cells were scraped in cold PBS using 
a cell scraper and collected in 15 mL falcon tubes. Tubes were centrifuged for 5 min at 700 x g, 4°C. 
Supernatants were aspirated and cells were resuspended in 500 µL of MIB. Cell suspensions were 
transferred to a Precellys tube containing silica beads. Following, the tissue was homogenised using a 
VelociRuptor V2 Microtube Homogeniser (Scientific Laboratories Supplies, UK) for 5 seconds. The 
homogenised solution was transferred to a 15 mL falcon tube and the solution was draw into a 5 mL 
syringe using a 19 gauge inch needle and expelled back into the tube using a 28 gauge inch syringe. 
This process was repeated 5 times. The solution was transferred to a 1.5 mL Eppendorf tube and 
centrifuged for 5 minutes at 600 x g, 4°C. The supernatant was carefully removed and transferred to a 
new 1.5 mL Eppendorf tube. Supernatant was centrifuged for 10 min at 11,000 x g, 4°C. The resulting 
supernatant was collected for cytosolic subcellular fractionation. The resulted pellet containing 
mitochondria was kept on ice. 
Mitochondria were resuspended in 1X RIPA buffer containing protease and phosphatase inhibitors 
(Roche). Next, the mitochondria was homogenised by needle (10 times). Homogenate was centrifuged 
for 10 min at 10,000 x g, 4°C. Finally, the supernatant was collected and protein concentration was 
measured by BCA protein assay (Bio-Rad). A concentration of 30 µg of protein was used to evaluate 
the protein carbonyl formation and α-tubulin. 
 
Determination of cellular glutathione (GSH and GSSG) levels 
Total GSH and GSSG levels were estimated as an index of oxidative stress by the GSH recycling assay 
according to the method described by [24]. Briefly, dSH-SY5Y cells were seeded in 12 -well culture 
plates at 2 x105 cells/well. After 24 h incubation, cells were scraped from the plate and washed twice 
with PBS. Sulfosalicylic acid (SSA; 3.33 µl of 100% made up in distilled water) was added to the cell 
pellet and vortexed for 10 seconds. Stock buffer (96.6 µl of 125 mM sodium phosphate, 6.3 mM 
disodium EDTA, pH 7.5) was added to each tube, vortexed and centrifuged at 6600g for 2.5 min and 
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supernatants were collected carefully and stored immediately at −80 °C prior to GSH analysis by 6mM 
DTNB (5,5'-dithiobis-(2-nitrobenzoic acid)) recycling assay. The yellow color was measured at 410 nm 
at 0, 1, 2, 5 and 10 minutes using the spectrophotometer.  
 
 
HPLC method development for carotenoid analysis 
Carotenoid analysis was carried out isocratically on an Agilent 1200 series high performance liquid 
chromatography (HPLC) instrument using a method adapted from [22]. Carotenoids were separated 
using a reversed phase Suplex pKb-100 HPLC Column 250x4.6mm, 5µm (Sigma Aldrich).  The mobile 
phase was 54%methanol, 44% acetonitrile, 2% (propan-2-ol, 15%water) at a flow rate of 1mL/min. 
Extracted carotenoids (99µL) were injected onto the HPLC. 
 The HPLC system comprised of a thermostatically controlled autosampler, a quaternary pump and a 
variable wavelength detector (VWD). Lutein and zeaxanthin were detected at 450nm and identified by 
their retention time and absorption spectrum compared with the characteristics of pure standards 
(>95%). Quantification was performed using the Agilent chemstation (Version B.03.01-SR1) in relation 
to the internal standard. Concentrations were calculated by comparing the peak heights with standard 
reference curves. Standard chromatograms are shown in (Supplementary figure 2). 
 
Determination of linear dynamic range, LOD and LOQ of lutein and zeaxanthin 
An external calibration curve was prepared for lutein and zeaxanthin for the determination of their linear 
range, LOD and LOQ. Calibration curves were produced by injecting authentic solutions between 0.01 
and 40µM. The concentration ranges selected for the calibration curves were based on preliminary data 
on the dynamic ranges. LOD and LOQ were calculated using the visual evaluation method from the 
ICH guidelines [25] and are reported in Supplementary Table 1. 
 
HPLC method precision, accuracy and recovery 
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Percentage recovery analysis was determined according to [26]. The recovery percentages were 
estimated by comparing the level of the carotenoid standards (lutein and zeaxanthin) with or without 
spiking into cells. Carotenoids were extracted as described earlier. We calculated recovery percentages 
for low, medium and high concentrations of lutein (0.1, 1, 10µM) and zeaxanthin (0.05, 0.5, 5µM). The 
accuracy of the method was determined for the optimum concentrations (1µM lutein and 0.5µM 
zeaxanthin) by calculating the mean of the experimental values with the actual concentrations of the 
standards. Recovery was calculated for six replicates of each compound and presented as a percentage 
of initial material. Precision is required to be within ±15%  and accuracy between 85- 115% [27] 
 
Analysis of POVPC levels 
 Cellular POVPC levels were determined by mass spectrometry as detailed in Ademowo et al. [19]. 
Lipid extracts (10 µl) were separated on an Acclaim C18 column (internal diameter 2.1 mm, column 
length 150 mm, particle size 3 µm, Thermo Scientific, UK) using the mobile phases consisted of (A) 
10 mM ammonium formate in methanol:water:formic acid (20:80:0.1, v/v/v) and (B) 2 mM ammonium 
formate in 2-propanol:methanol:formic acid (90:10:0.1, v/v/v) at 45 °C. Flow rate was maintained at 
100 µl/min with the gradient as follows: 30% B from 0 to 5 min, 30–70% B from 5 to 20 min, 70–100% 
B from 20 to 35 min, 100% B 35–40 min, 100–30% B from 40 to 41 min, 30% B 41–51 min. The 
POVPC analyte eluted at 20.8 min while the ISTD, dPOPC eluted at 30.8 min. 
 
Mitochondrial function assay 
Mitochondrial function of dSH-SY5Y cells was measured using Agilent Seahorse XF24 Extracellular 
Flux Analyzer that allows the determination of oxygen and proton concentrations in real time [28]. 
dSH-SY5Y cells were seeded in the XF24 culture plates at 80,000 cells/well, a day prior to treatment. 
Cells were treated with POVPC ± carotenoid for 24 hours as indicated. On the day of assay, cells were 
incubated in assay medium containing (1mM sodium pyruvate, 2mM glutamine, 10mM glucose) in a 
CO2-free incubator for 1 hour prior to the assay in order to de-gas solutions. The Seahorse protocol 
consisted of calibration/equilibration step, followed by the synchronised injection of drugs and reagents 
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in each of three different ports. Ports were loaded with oligomycin – ATP synthase inhibitor, FCCP –
oxidative phosphorylation uncoupler; and a mixture of rotenone/antimycin A – inhibitors of respiratory 
complexes 1 and 111 respectively [29]. 3min mix, 2min wait and 3min measure cycles were used; three 
baseline measurements were taken before and a subsequent three measurements were taken after drug 
additions. Data were expressed as the rate of oxygen consumption (OCR) in pmol/min. Cell numbers 
(80,000 cells/well), Oligomycin (1μM), FCCP (1μM) and antimycin A/Rotenone (0.5/0.5μM) 
concentrations were optimised prior to assay. Our optimum Seahorse reagent concentrations agree with 
Schneider et al. [1]. 
Respiratory parameters were measured by calculating respiration rates before and after the addition of 
electron transport chain inhibitors. The parameters calculated included ATP production (baseline 
respiration minus oligomycin post injection respiration);  and proton leak (oligomycin respiration minus 
rotenone / antimycin A post injection respiration) [30]. Optimal concentrations of oligomycin, FCCP, 
and antimycin A/Rotenone were diluted in assay media and 75μL of each stock solution was loaded 
onto an XF24 cartridge. The microplate was loaded into the Seahorse XF24 analyser according to the 
manufacturer’s instruction. Experiments were carried out at 37°C. The OCR were automatically 
calculated, recorded, normalised with protein concentration and plotted by Seahorse XF24 software 
(Wave Desktop Version 2.4). 
 
MitoSOX oxidation analysis 
SH-SY5Y cells were seeded in a 24-well plate at 2x105 cells/well. After 10 days of differentiation, cells 
were treated with POVPC and carotenoids; POVPC (1µM, 20 µM, 50 µM) and carotenoids (lutein and 
zeaxanthin). 24 hours after the cells were POVPC ± carotenoid treated, the cells were incubated with 
media containing 5µM MitoSOX Red Probe in a 37°C incubator for 10 minutes, protected from light. 
The media was removed and replaced with 0.5mL measurement buffer (PBS with Ca2+ /Mg2+). 
Fluorescence was measured with a microplate reader (510nm excitation / 595nm emission); with the 
measurement buffer as the blank. MitoSOX oxidation values were normalised against protein 
concentration and calculated as a percentage of the control. 
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Statistical analysis:  
Results are expressed as mean ± standard error of mean (SEM). Statistical analysis was performed using 
Graphpad Prism software (version 7). One-way analysis of variance (ANOVA) was used to compare 
the effects of different concentrations of POVPC. The effects of carotenoid on cells were measured 
using two-way ANOVA. Post hoc comparisons between groups were made using Dunnett’s multiple 
comparison test / Tukey׳s test. All results are means of three independent experiments performed in 
triplicates (except where otherwise stated) and p< 0.05 was considered significant. 
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RESULTS 
POVPC toxicity in dSH-SY5Y cells is associated with oxidative stress 
dSH-SY5Y cells were exposed to increasing concentrations of POVPC (1, 20µM and 50µM) for 24 
hours. Lower concentrations of POVPC did not affect viability, but significant cell death (~25%) was 
observed after co-incubation for 24 hours with 50µM POVPC (p<0.05; Figure 1A). To confirm that 
POVPC is taken up by neuronal cells, we analyzed the POVPC levels in cells before and after carotenoid 
supplementation by our multiple reaction monitoring (MRM) mass spectrometry method. Figure 1B 
confirms that POVPC is detectable in cells at different concentrations according to exposure, 
confirming that POVPC was delivered into cells. Despite the lack of toxicity following 20µM POVPC 
exposure, significantly increased concentrations of the oxPL were recovered in neurones after 24h 
compared to untreated control cells (Figure 1B). At non-toxic concentrations of POVPC, a 
concentration-dependent increase in oxidative stress was observed, determined as a significant decrease 
in total glutathione levels after exposure to > 1µM POVPC and a significant ~50% increase in 
mitochondrial ROS production at 20µM POVPC (Figures 1C and 1D). Confirmation of MitSOX    
oxidation was achieved by microscopy (Supplementary Figure 3).    
To understand whether mitochondria were oxidatively modified by POVPC after 24 hours treatment, 
we isolated mitochondria by centrifugation and analysed mitochondrial protein carbonyls by Western 
blot. There was a dose-dependent increase in protein carbonyl content as determined by Image J analysis 
that was more evident in some lower MW bands than others (Figures 1E). In both experimental 
replicates, the tubulin housekeeping band intensity was lower after 20µM POVPC treatment, for 
equivalent protein loading (Figure 1F).  
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Figure 1.  Exposure of dSH-SY5Y cells to POVPC decreases cell viability, causes toxicity and 
oxidative stress in a concentration-dependent manner over 24 hours. Data (A-D) are expressed as 
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means ± SEM of 3 independent assays and in triplicates and differences were evaluated by ANOVA.  
*p<0.05 compared to untreated control. Figure 1E and 1F are representative of two independent blots 
of mitochondrial proteins stained for protein carbonyls (1E) with mitochondrial tubulin as a loading 
control (1F). 
 
 
Carotenoid uptake and antioxidant activity in dSHSY5Y 
To confirm that carotenoids were taken up by neuronal cells, cells were lysed after 24-hour incubation 
in the presence of increasing concentrations of lutein or zeaxanthin. We were not able to detect lutein 
in cells treated with low concentrations of the carotenoid (0.1 µM) possibly reflecting its consumption 
to below detectable levels over 24 hours; however, at 1 µM lutein recovery was estimated at 72.8% 
(Table 1). Similarly, at the lowest concentration of zeaxanthin investigated (0.05 µM) we were not able 
to detect any uptake into cells, however, at 0.5 and 5 µM zeaxanthin, 80 and 43.6% uptake were 
measured.  
 
Table 1: Precision, accuracy and % recovery of carotenoids from SHSY5Y cells 
 
Carotenoid Concentration 
added (µM) 
Concentration 
recovered 
(µM) 
% Recovery  Accuracy 
(%) 
%CV 
Lutein      
 0.0 0.0     0.0   
 0.1 0.0     0.0   
 1.00 0.73±0.03 72.8 90.0 5.81 
      
Zeaxanthin      
 0.0 0.0     0.0   
 0.05 0.0     0.0   
 0.5 0.40±0.02 80.3 106.0 6.86 
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 5.0 2.18±0.14 43.6   
n=6 
 
HPLC chromatograms and calibration curves are shown in supplemental Table 1. The accuracy was 90-
106% and %CV of 5-7% [27]. The limit of detection (LOD) for lutein, zeaxanthin and the internal 
standard are 0.1, 0.1 and 0.05µM respectively while the limit of quantification (LOQ) for lutein, 
zeaxanthin and the internal standard are 0.5, 0.5 and 0.2µM respectively. 
 
Following coincubation of dSHSY-5Y cells with lutein (0.1 and 1 µM), there was no loss of viability 
(Figure 2A). In addition, there was a significant decrease in mitochondrial ROS production (Figure 2C) 
without effect on total GSH (Figure 2B). Interestingly, the presence of POVPC increased expression of 
the mitochondrial antioxidant enzyme, SOD2 (Figure 2D).  
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Figure 2.  Exposure of dSH-SY5Y cells to carotenoid reduced oxidative stress over 24 hours. Data 
are expressed as means ± SEM of 3 independent assays and in triplicates and differences were evaluated 
by one way ANOVA.  *p<0.05 compared to untreated control 
 
Carotenoids partially protect against toxicity and oxidative stress induced by POVPC in dSH-
SY5Y cells  
In order to investigate any protective effect of carotenoids against POVPC-induced oxidative stress, we 
determined cell viability and intracellular total GSH in dSH-SY5Y cells treated with POVPC in the 
presence or absence of carotenoids for 24 hours. The combination of POVPC and carotenoids did not 
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affect cell viability over the concentration ranges used here (Figure 3a and b). Both carotenoids were 
protective against the loss of GSH induced by 1uM POVPC but had no effect on the changed cellular 
GSH levels due to 20µM POVPC. GSSG concentration was almost doubled by 20 but not 1 µM POVPC 
and in the presence of lutein or zeaxanthin (0.05 µM) alone, GSSG concentration was halved Figure 
3D).                                                  
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Figure 3. Effect of carotenoids on POVPC-induced loss of total GSH, GSSG levels and viability. 
Data are expressed as means ± SEM of 3 independent assays and in triplicates apart from GSSG thatw 
as determined in duplicate.    
 
Effects of carotenoids on POVPC-induced mitochondrial ROS  
To ascertain whether carotenoids protected against POVPC-induced mitochondrial ROS production, 
MitoSOX red, a mitochondrial superoxide indicator was used. Figure 4 confirms that the presence of 
carotenoids reduced mitochondrial stress by ~50% in the presence of 20µM POVPC compared to 
controls. The increase in MitoSOX oxidation induced in 20µM POVPC treated cells was mitigated by 
the presence of any carotenoid treatment whereas no significant effect was seen at lower POVPC 
concentrations.  
 
 
Figure 4.  Carotenoids protect against of POVPC (20µM) induced MitoSOX oxidation in dSH-
SY5Y cells. Data are expressed as means ± SEM of 3 independent assays and in triplicates and 
differences were evaluated by ANOVA. *** P<0.001 compared to no carotenoid control 
 
Effects of POVPC and carotenoids on mitochondrial respiration in neuronal cells 
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Mitochondria serve as important stores for intracellular GSH which in turn protect from uncoupling and 
apoptosis. From earlier experiments, we have confirmed oxidative stress was induced with 1 and 20µM 
POVPC concentrations and showed some protective effects of carotenoids against POVPC. We 
therefore analysed mitochondrial respiration using the Seahorse Extracellular Flux Analyser in 
neurones treated with different concentrations of POVPC and carotenoids. Figure 5A shows that 1µM 
POVPC treatment did not significantly affect mitochondrial function. However, 20µM POVPC- treated 
cells showed significant proton leak which associated with POVPC concentration dependent loss of 
ATP production. While apparent proton leak induced by 20µM POVPC was prevented by zeaxanthin 
and lutein  (Figure 5A), ATP production was not significantly rescued with carotenoid supplementation 
Figure 5B.  In order to evaluate whether this effect was due to mitochondrial number, we determined 
copy number. There was no effect of POVPC treatment due to change in mitochondrial content in cells 
(Figure 5C). 
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Figures 5. Mitochondrial stress test of SH-SY5Y cells treated with POVPC and carotenoids. Data 
are expressed as means ± SEM of 3 independent assays and differences were evaluated by ANOVA # 
p≤ 0.0001 compared to no carotenoid control; #p< 0.05 compared to no carotenoid control. 
DISCUSSION 
Cross-sectional studies have shown that plasma oxocarotenoid concentrations correlate positively with 
cognitive function in older adults [9,13,18,31,32]. In addition, dietary patterns of higher oxocarotenoid 
dietary intake associate with lower risk for cognitive decline in cohort studies. It is known that 
oxocarotenoids can act as antioxidants in vitro; however, few have investigated the underlying 
mechanism in detail. Here we have shown for the first time that lutein and zeaxanthin are taken up by 
neuronal cells and protect neuronal mitochondria from loss of function induced by the OxPL, POVPC. 
These findings suggest that mitochondrial function merits investigation as a biomarker of oxocarotenoid 
benefit. 
Previous studies showed that exogenous POVPC is toxic as it is readily internalized, migrates to and 
damages the mitochondria [5]. Neurones rely on mitochondria to meet energy demands, and 
dysfunction of oxidative phosphorylation associates with several neurological disorders. In addition, 
mpaired mitochondrial function is frequently observed in neurodegenerative diseases such as 
Alzheimer’s disease [33–35].  Others have shown that POVPC could induce oxidative stress and 
impairs mitochondria function in a dose-dependent manner; 50µM oxidised phospholipid (PGPC and 
POVPC) induced apoptosis in macrophages [6,36]. 
Our study shows for the first time that the oxPL POVPC (1µM) induced neuronal oxidative stress while 
preserving metabolic function in vitro, however, a higher sublethal concentration of POVPC (20µM) 
caused mitochondrial proton leak, loss of GSH, an increase in SOD2 expression and inhibition of 
mitochondrial ATP production.   The decrease in metabolic activity that we observed with >20µM 
POVPC agrees with previous studies of Stemmer et al. [6].  
The uptake, distribution and metabolism of carotenoids have been attributed to the activities of different 
protein transporters (SR-BI, CD36, NPC1L1), digestion enzymes (PNLIP, CES), cleavage enzymes 
23 
 
(BCO1/2), intracellular transporters (FABP2) and receptors (LPL, APOC/E, LDLR). It is predicted that 
carotenoids are bioavailable for many cell types [37].  Using recovery studies, here we have confirmed 
the uptake of carotenoids by (d)SHSY5Y cells.  
The differential distribution and specificity of carotenoid cleavage enzymes, BCO 1 and 2 led us to 
speculate that mitochondria may be an important target for neuronal protection by oxocarotenoids, 
because lutein and zeaxanthin are metabolised by BCO2 which is located within mitochondria.  
The Seahorse Extracellular flux analysis has emerged as a powerful tool to study mitochondrial 
bioenergetics [29] suggesting possible causes of mitochondrial dysfunction and an in-depth 
understanding of metabolic pathways, signals, and phenotypes and enables the calculations of 
mitochondrial and non-mitochondrial respiration. Exposure of cells to POVPC with and without 
carotenoids inhibited mitochondrial respiration. Proton leak and ATP production efficiency were 
significantly impaired in a dose-dependent manner. Proton leak and non-mitochondrial respiration (data 
not shown) was higher in 20µM POVPC treated cells compared to 1µM POVPC treated cells. This 
observation was independent of copy number suggesting the absence of mitophagy at the concentrations 
of POVPC studied here. However, we did observe an increase in protein carbonyl formation in 
mitochondria isolated from POVPC treated cells, suggesting they may be susceptible to oxidative 
damage.   
Here, we showed that delivering zeaxanthin and lutein at concentrations similar to those seen in plasma 
was able to protect against mitochondrial proton leak and ROS production but did not mitigate against 
loss of glutathione or loss of mitochondrial ATP production by higher POVPC (20µM) concentration. 
Despite preventing proton loss, carotenoids could not restore mitochondrial ATP production in cells 
exposed to higher POVPC concentrations, probably due to sustained GSH depletion. Oxidised GSH is 
depleted from cells by transport extracellularly when its capacity for reduction is exceeded. It is possible 
that the loss of ATP may reflect a switch of cell metabolism towards the pentose phosphate pathway, 
away from mitochondria, to produce NADPH and enable effective reduction of GSH. 
Neurones have high energetic requirements, primarily using glucose as the energy substrate. They are 
highly susceptible to alteration of mitochondrial function leading to glucose hypometabolism [38]. It 
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has been proposed that maintaining mitochondrial metabolism may support neuronal survival. In 
support of this, metformin administration improves neuronal survival and mitochondrial function in 
preclinical studies of Alzheimer’s disease (AD) [39].  
Previous studies have shown that mitochondrial-targeted antioxidants are capable of maintaining blood 
flow, mitochondrial function and physiological redox state in mice [40], again supporting the hypothesis 
that ROS may arise from and lead to mitochondrial dysfunction. The mechanism by which lutein and 
zeaxanthin protect neuronal tissue against degenerative diseases has been suggested to be due to their 
lipid-soluble singlet-oxygen quenching antioxidant property which is related to their localisation and 
orientation within the lipid membrane [41,42].  
Carotenoids such as lutein and zeaxanthin are able to penetrate membranes due to their lipophilicity 
and may be able to restore mitochondrial function under low stress conditions [11]. Carotenoids are 
effective modulators of the physical properties of both natural and model membranes, increasing their 
rigidity and thermostability [43].  Oxo-carotenoids stabilize membranes to a greater extent than β-
carotene; they are incorporated into bilayers and span the membrane with their lipophilic core, being 
further anchored in the aqueous area with –OH groups, thus functioning like a molecular rivet [43,44]. 
Our observation that oxocarotenoids counteract POVPC-dependent proton leakage presents the 
possibility that POVPC may otherwise target and disrupt physical properties of the mitochondrial 
membrane causing loss of membrane stability and function. 
 Bohn, [31] reviewed the strength of evidence between carotenoid intake and changes in oxidative stress 
in human observational studies and intervention trials in health and diseases, proposing that  circulating 
levels of carotenoids can be used as markers for total mortality. We and others have shown inverse 
correlations between plasma concentrations of lycopene, lutein, zeaxanthin, meso-zeaxanthanin but not 
carotene with circulating levels of peroxidised lipids in dementia patients. In older adults, lutein and 
zeaxanthin supplementation have been shown recently to facilitate the brain capacity for cognitive 
compensation in an fMRI study of healthy ageing; this showed the integration between different 
networks that are functionally segregated earlier in the lifespan. This study lends some credence to the 
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concept that any protective effect of oxocarotenoids on cognitive function should be evaluated in 
prodromal stages of disease [45]. 
 
CONCLUSION 
Physiological concentrations of oxidized phospholipid induced neuronal oxidative stress, but not a 
bioenergetic deficit, that can be mitigated by the xanthophyll carotenoids in a dose dependent manner. 
However, delivery of carotenoids did not protect neuronal cells from elevated oxidised phospholipid 
concentrations, probably due to GSH depletion and mitochondrial dysfunction. 
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Supplementary Figure 1 
 
SHSY5Y cells      dSHSY5Y cells (day 10) 
  
Light microscopy images of SHSY5Y cells with and without differentiation for 10 days with 
retinoic acid  
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Identification of carotenoids with HPLC  
 
 
Supplementary Figure 2 
The structures and the chromatograms for A) lutein (C40H56O2), B) zeaxanthin (C40H56O2) and C) Apo-
β-carotenal (C30H40O). Lutein eluted at 4.47 min, zeaxanthin eluted at 4.84min and the internal standard, 
apo-β-carotenal eluted at 5.14min under isocratic conditions. The hydroxyl group at the C-3′ position 
in lutein (3R, 3′R, 6′R-β,ε-carotene-3,3′-diol) is configured exactly opposite to that of zeaxanthin (3R, 
3′R-β,β-carotene-3,3′-diol). 
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Visualisation of mitochondrial ROS using mitoSOX 
MitoSOX Fluorescence 
SH5YSH cells were seeded in a 24 culture well plate at 2x105 cell/ml as described above until 
confluent. After treatment, medium was replaced by DAPI (diamidinophenylindole, Abcam) in 1:10 
dilution in fresh medium with an incubation of 10 minutes at 37 ° C. Subsequently, 5 µM MitoSOX 
(Sigma) in RPMI medium was added to the wells and incubated for 20 minutes. The medium was 
removed and cells were washed twice with PBS 1x and resuspended in fresh medium. Fluorescence 
image stained was visualized by Nikon (Ti-E live cell imaging system, UK) and the analysis by Image 
J 1.80 software (NIH).  
 
 
Supplementary Figure 3. Mitochondrial ROS production is more frequent in dSHSY5Y cells after 
treatment with POVPC for 24 hours 
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LOD, LOQ and the calibration curve obtained from carotenoid standards 
 LOD LOQ            Calibration curve 
Carotenoid standards  (µM) (µM) Equation R 
Lutein  0.1 0.5 y= 28.37x + 3.881 0.999 
Zeaxanthin 0.1 0.5 y= 45.12x – 2.021 0.998 
Apo-β-carotenal 0.05 0.2 y= 82.65x + 30.980 0.998 
 
Supplementary Table 1 
LOD and LOQ were calculated using the visual determination, expressed as the analyte concentration. 
R is the correlation coefficient, x is the injected amount in µM and y is the peak height. Calibration 
curves were produced by injecting 0.01, 0.05, 0.1, 0.5, 1, 2, 5, 10, 15, 20, 25, 30 and 40 µM of the 
analytes. Lutein and zeaxanthin were linear between 0-40 µM while the internal standard (Apo-β-carotenal) 
was linear between 0-30 µM. 
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